Research library
Guides and research notes.
Written for practice managers, clinicians buying for research programs, and lab staff. Chemistry, analytics, paperwork and the published literature. Nothing here is a usage guide.
AllCompound researchCertificates & testingHandling & storageComparisonsBuying & regulatoryPeptides 101

VIP (Vasoactive Intestinal Peptide): What the Research Literature Covers
VIP explained for the lab: the 28-residue sequence, VPAC1 and VPAC2 receptor pharmacology, the aviptadil development history and its status, and why the peptide is hard to keep stable.
October 21, 2026 · 10 min read

SNAP-8 (Acetyl Octapeptide-3): The Cosmetic-Science Peptide in the Research Literature
SNAP-8 (acetyl octapeptide-3) explained: its sequence, the SNARE-mimic hypothesis from SNAP-25 biology, what is in vitro only, and how cosmetic-grade differs from research-grade material.
October 21, 2026 · 10 min read

TH9507: The Stabilized GHRH Analog in the Research Literature
TH9507 is GHRH(1-44) with a trans-3-hexenoyl cap that blocks DPP-IV. The plasma-stability, receptor, animal and volunteer papers, the Egrifta approval, and what a research vial is not.
October 21, 2026 · 10 min read

Sermorelin (GHRH 1-29): What the Research Literature Covers
Sermorelin is GHRH(1-29)-NH2. The rat pituitary structure-activity papers, the cloned receptor and its cryo-EM structure, DPP-IV cleavage, and the Geref approval and 2008 discontinuation.
October 21, 2026 · 10 min read

Melanotan I and Melanotan II: Alpha-MSH Analogs in the Research Literature
Melanotan I (afamelanotide) and Melanotan II are structurally different alpha-MSH analogs. Receptor binding data, the Arizona origin papers, the Scenesse approval, and the warnings on MT-II.
October 21, 2026 · 11 min read

LL-37: The Human Cathelicidin Peptide in the Research Literature
LL-37 is the 37-residue C-terminal peptide of the only human cathelicidin. Its 1995 discovery, membrane biophysics, immunology cell studies, microbiology-lab role, and certificate points.
October 21, 2026 · 11 min read

Ipamorelin: The Selective Ghrelin Receptor Agonist in the Research Literature
Ipamorelin is a synthetic pentapeptide agonist of the ghrelin receptor. The 1998 Novo Nordisk characterization, receptor cloning and structure, volunteer PK data, and the ended Helsinn program.
October 21, 2026 · 10 min read

IGF-1 LR3: The Long-R3 Analog in the Research Literature
IGF-1 LR3 is an 83-residue recombinant IGF-1 analog built in 1992 to escape binding proteins. The design papers, NMR structure, cell-culture role, and what its certificate should show.
October 21, 2026 · 11 min read

Glutathione: Tripeptide Chemistry, Oxidation, and the Research Literature
Glutathione is a gamma-linked tripeptide whose thiol oxidizes in solution. The GSH/GSSG redox pair, why solutions degrade, assay methods, reagent uses, and its US regulatory history.
October 21, 2026 · 10 min read

GHRP-2 and GHRP-6: The First-Generation Growth Hormone Releasing Peptides
GHRP-6 and GHRP-2 are designed hexapeptides from Bowers' 1980s program. How they led to the GHS-R1a receptor and ghrelin, what cell and animal studies measured, and their status.
October 21, 2026 · 11 min read

CJC-1295 With and Without DAC: Chemistry and the Research Literature
CJC-1295 names two molecules: a four-substitution GHRH(1-29) analog and the same peptide with an albumin-binding maleimide. The chemistry, the rat and volunteer papers, and the ended program.
October 20, 2026 · 11 min read

ARA-290 (Cibinetide): The Erythropoietin-Derived Peptide in the Research Literature
ARA-290 (cibinetide) is an 11-residue peptide copied from the aqueous face of erythropoietin's helix B. The receptor hypothesis, rodent studies, clinical program, status, and COA notes.
October 20, 2026 · 10 min read

AOD-9604: The hGH Fragment 176-191 in the Research Literature
AOD-9604 is a disulfide-bridged 16-residue fragment of human growth hormone. The Monash origin, what rodent and tissue studies measured, the ended clinical program, and the GRAS claim explained.
October 20, 2026 · 10 min read

SS-31 (Elamipretide): The Cardiolipin-Targeting Tetrapeptide in the Research Literature
SS-31 (elamipretide) chemistry, the cardiolipin-binding mechanism papers from 2004 to 2020, the trial record, and the September 2025 Forzinity approval, for research buyers.
October 20, 2026 · 10 min read

PT-141 (Bremelanotide): Melanocortin Receptor Research and Regulatory History
PT-141 (bremelanotide): the cyclic lactam structure, its one-dalton difference from Melanotan II, melanocortin receptor pharmacology, the 2020-21 MC4R structures, and the Vyleesi distinction.
October 20, 2026 · 10 min read

Oxytocin: Structure, the Disulfide Bridge, and the Research Literature
Oxytocin's nonapeptide chemistry and Cys1-Cys6 ring, its two-residue difference from vasopressin, the 1992-2025 receptor structures, solution degradation data, and the Pitocin distinction.
October 20, 2026 · 10 min read

Kisspeptin-10: The Metastin Fragment in the Research Literature
Kisspeptin-10 explained: the KISS1 fragment nomenclature, the 2001 receptor discovery papers, GPR54/KISS1R genetics, structure-activity work, and its unapproved status.
October 20, 2026 · 9 min read

Gonadorelin: The Synthetic GnRH Decapeptide in the Research Literature
Gonadorelin explained: the native GnRH decapeptide sequence, the tail-less GnRH receptor, how it differs from leuprolide, and its discontinued-human, current-veterinary approval record.
October 20, 2026 · 10 min read

Dihexa: Why It Is Classed Differently and What the Literature Actually Says
Dihexa explained: an angiotensin IV-derived small molecule, the HGF/c-Met hypothesis from one laboratory, the thin literature and 2025 retractions, and why most vendors skip it.
October 20, 2026 · 10 min read

Thymosin Alpha-1: What the Research Literature Covers
Thymosin alpha-1 is a 28-residue acetylated thymic peptide, approved abroad as thymalfasin but not in the US. Its chemistry, structure, immunology studies, and certificate notes.
October 20, 2026 · 11 min read

Semax: The ACTH(4-10) Analog in the Research Literature
A model-by-model survey of the Semax literature: binding and BDNF studies, rat ischemia transcriptomics, copper chemistry, the N-acetyl amidate variant, and regulatory status.
October 20, 2026 · 12 min read

Selank: The Tuftsin Analog in the Research Literature
A survey of the Selank literature by model: plasma enkephalinase assays, GABA-A radioligand and slice work, mouse spleen cytokine genes, rodent behavior, and the Russian clinical record.
October 20, 2026 · 12 min read

Pinealon (Glu-Asp-Arg): A Khavinson Tripeptide in the Research Literature
What is published on Pinealon (Glu-Asp-Arg): ROS and proliferation cell assays, DNA-binding biophysics, rodent models, the bioregulator hypothesis, and evidence quality.
October 20, 2026 · 11 min read

NAD+: Why It Is Not a Peptide and What the Research Covers
NAD+ is a dinucleotide coenzyme, not a peptide. Its salvage pathway, the age-decline and precursor literature in mice and humans, and why it is so unstable in solution.
October 20, 2026 · 11 min read

MOTS-c: The Mitochondrial-Derived Peptide in the Research Literature
MOTS-c is a 16-residue peptide encoded in mitochondrial 12S rRNA. What the 2015 Cell Metabolism paper, the nuclear-translocation work, rodent models, and human cohorts report.
October 20, 2026 · 11 min read

KPV: The Alpha-MSH Tripeptide Fragment in the Research Literature
KPV is Lys-Pro-Val, the last three residues of alpha-MSH. What human cell, mouse, rat, and rabbit studies report, the unresolved mechanism, and why it is in the KLOW blend.
October 20, 2026 · 11 min read

Khavinson Short Peptides: Vilon, Vesugen, Testagen, and Prostamax Explained
Vilon (KE), Vesugen (KED), Testagen (KEDG), and Prostamax (KEDP): sequences, the bioregulator hypothesis, what single-group studies measured, and the limits of the evidence.
October 20, 2026 · 12 min read

Humanin: The First Mitochondrial-Derived Peptide in the Research Literature
Humanin is a 24-residue peptide encoded inside the mitochondrial 16S rRNA gene. The 2001 discovery, its binding partners, rodent and human-sample data, and its relation to MOTS-c.
October 20, 2026 · 12 min read

GHK-Cu Copper Peptide: What the Research Literature Covers
GHK-Cu is a tripeptide-copper complex first isolated from human plasma in 1973. What fibroblast, rodent, and gene-expression studies report, and what remains unestablished.
October 20, 2026 · 12 min read

DSIP (Delta Sleep-Inducing Peptide): What the Research Literature Covers
DSIP is a nonapeptide named for a 1977 rabbit EEG finding. Why replication has been inconsistent, what the chemistry and immunoreactivity studies show, and what recent papers report.
October 20, 2026 · 12 min read

Adamax: What the Name Covers and What Is Actually Published
Adamax is a vendor name for adamantane-conjugated Semax with no published studies of its own. What the Semax and adamantane literatures do show, and how to read a claim.
October 20, 2026 · 12 min read

5-Amino-1MQ: A Small-Molecule NNMT Inhibitor in the Research Literature
5-Amino-1MQ is a quinolinium small molecule, not a peptide, that inhibits NNMT. What the enzymology, adipocyte culture, and mouse studies report, and the absence of human data.
October 20, 2026 · 11 min read

TB-500 and Thymosin Beta-4: What the Research Literature Covers
Thymosin beta-4 is a 43-residue actin-binding protein; TB-500 is a 7-residue fragment. What the literature reports for each, and where the human evidence gap sits.
October 20, 2026 · 12 min read

BPC-157: What the Published Research Covers
A model-by-model survey of the BPC-157 literature: cell culture, rodent, animal toxicology, and the small uncontrolled human record, plus regulatory status.
October 20, 2026 · 11 min read